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ABSTRACT
The advent of new chemical genetic tools and high-throughput screening technologies and 
platforms have already led and will continue to lead in accessing the natural product diversity 
of microorganisms. This thesis represents a continuation of the work on the investigation into 
means of making better use of the advantages of new technologies and the OSMAC approach 
(One Strain Many Compounds) in drug discovery that the Atta-ur-Rahman Research Institute 
of Natural Product Discovery (RiND) at MARA University of Technology has engaged in.
The result of this thesis is the MECSUS (Microtiter plate, Elicitors, Combination, Solid phase 
extraction, UHPLC, Statistical analysis) protocol. It involves miniaturized parallel 
fermentations in 96-well microtiter plate with up to ninety six different media, parallel 
extraction of the supernatant layer of the fungus via a polymer based solid phase extraction
✓
(SPE) plate, chromatographic assessment of the results via UHPLC, and multivariate analysis 
of the chromatogram s. The aforementioned protocol introduces elements of incremental 
novelty in the natural product screening program by means of combining and harnessing 
existing ideas, techniques, and technologies into a protocol for the implementation of the 
OSMAC approach at micro-scale. Its main advantage is the decrease of the scale of operation 
with the use of the 96-well microtiter plates. It’s benefits includ the possibility of overcoming 
few issues such as processing time and human resources that have somewhat hampered the 
implementation of the OSMAC approach and/or the systematic study of a large library of 
microorganisms. As a proof of concept for the MECSUS protocol, further evaluation on the 
metabolic potential of the already known fungus, Aspergillus sp. HAB10R12, was carried out 
through systematic alteration of the composition of the cultivation media by adding minerals 
and epigenetics elicitors. Computational analysis of the resulting 384 UHPLC chromatograms 
showed that the secondary metabolite production of Aspergillus HAB10R12 was altered by 
the use of sub-inhibitory concentrations of epigenetic elicitors. Various doses of the epigenetic 
modifiers suberoylanilide hydroxamic acid (SAHA), valproic acid, sodium butyrate, and 
SAHA + S-adenosylhomocysteine stimulated Aspergillus HAB10R12 secondary metabolite 
production.Chemical characterization of Aspergillus HAB10R12 extract, UV and Mass 
values, confirmed the identity of the series of peptides and pyrones previously identified, and 
revealed that the fungus extract is rich in compounds that potentially exceed the ones listed 
above. Cytotoxicity tests revealed the crude extract as well as the purified metabolites of 
Aspergillus HAB10R12 are potent cytotoxic compounds.
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